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1. Introduction
The human central nervous system (CNS) may be affected by infections of several species in
the Schistosoma genus that infect men. One of the CNS clinical presentation is the spinal cord
schistosomiasis, a potentially severe disease, yet, for a long time, a poorly recognized clinical
presentation of Schistosomiasis. However, recently, probably as a consequence significant
improvements in diagnostic methods, more attention is being given to this clinical form of
Schistosomiasis. This emerging medical and scientific interest about the spinal cord schisto‐
somiasis has allowed a better comprehension of its clinical impact and importance as a pre‐
viously unrecognized public health problem.
Schistosomiasis  is  among the parasitic  diseases  with the highest  epidemiological  impor‐
tance in the world.  According to the World Health Organization,  schistosomiasis occurs
in  76  countries  and  230  million  individuals  require  treatment  annually  [1,2].  Of  these,
about  100  million  present  some  clinical  manifestation  and  20  million  present  severe
forms of the disease [1-5].  Annually,  over 200.000 people die as a consequence of schis‐
tosomiasis.  In the year 2010,  around 33.5 million people were treated.  Despite advances
in  the  control  of  the  disease,  with lowering of  mortality  and morbidity,  schistosomiasis
still  represents  a  challenge  to  public  health  and  has  increased  its  area  of  transmission
throughout the years [2].  Since it  hits  the poorer regions of  the world,  being associated
with precarious sanitary and adverse social-economical conditions,  this disease has been
neglected. With the increase of migratory flow and adventure tourism travels, innumera‐
ble  schistosomiasis  cases  have  been  occurring,  even  in  non-endemic  countries  [6-13].
Schistosomiasis  is  a  disease  caused by  trematode  worms,  belonging  to  the  Schistosoma
genus.  There  are  many  species  which  affect  man  in  different  clinical  manifestations,
elimination  methods,  intermediary  hosts  and  geographical  distribution.  These  species
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share the same pattern in reproductive cycle, the transmission occurring through eggs, a
proportion of  which are  eliminated through urine  (S.  haematobium)  or  feces  (S.  mansoni,
S.  japonicum  and  others).  These  eggs  release  larvae  (miracidium)  that  infect  freshwater
molluscs  in  which  the  parasites  multiply  through asexual  reproduction.  These  molluscs
release  aquatic  larvae  (cercariae)  that  actively  penetrate  the  skin  of  a  new,  vertebrate
host. These larvae become adults that inhabit inside the veins in the digestive system (S.
mansoni  and  S.  japonicum)  and  of  the  urinary  system  (S.  haematobium).  The  geographic
distribution of  each species  is  varied and depends on the  presence of  molluscs  capable
of serving as hosts  (each Schistosoma  species has different molluscs as hosts).  Precarious
sanitary  conditions  also  contribute  in  the  definition  of  locations  where  schistosomiasis
occurs [14]. Schistosoma mansoni occurs in 74 countries located in Africa, the Middle East,
South  America  and  the  Caribbean.  Its  eggs  measure  about  60  x  140  μm,  with  lateral
spine  and  are  eliminated  in  the  feces,  being  a  main  cause  of  intestinal,  hepatosplenic,
cardiopulmonary and cerebral  diseases,  aside from being the main cause of  spinal  cord
schistosomiasis.  S.  haematobium  occurs  in  Africa  and  in  the  Middle  East  and  its  eggs
measure  about  60  x  150  μm,  with  terminal  spine,  are  eliminated  in  the  urine  and  on
rare  occasions  in  the  feces,  being  the  mains  cause  of  urinary  diseases  and  spinal  cord
schistosomiasis.  S.  japonicum,  S.  mekongi  and  S.  malayensis  occur  in  Asia  (they  are  also
called S. japonicum-like); eggs measure about 60 x 100 μm, lack spine and are eliminated
in the feces, causing hepatic diseases, cerebral neuroschistosomiasis, although there have
been rare reports of cases in which spinal cord schistosomiasis was caused by S. japoni‐
cum.  S. intercalatum occurs in Africa. Eggs are eliminated in the feces. It causes mild in‐
testinal disease but not neuroschistosomiasis, being the least important species, clinically.
The presence of spines in the eggs of S. mansoni  and S.  haematobium  might explain why
medullar  and  cerebral  neuroschistosomiasis  are  more  common  in  these  species.  Spine
makes it  more difficult  for  the eggs to travel  through the vertebral  veins,  causing them
to be stuck in the lumbar or  thoracic  spinal  cord.  S.  japonium's  eggs,  being smaller  and
lacking spine,  migrate  more easily  to  the brain through these  veins,  crossing the spinal
cord without sticking to it. There are, still, species belonging to the Schistosomatidae fami‐
ly (ex: Trichobilharzia regenti) that can cause cercarial dermatitis (or summer's itch) with‐
out,  however,  reaching  adult  life  in  men  and,  therefore,  not  having  any  major  clinical
importance.
2. Clinical forms of schistosomiasis
2.1. Acute phase
Acute forms are basically cercarial dermatitis or summer's itch, cutaneous lesion secondary
to the penetration of the skin by the cercaria, and Katayama's fever (or syndrome), which is
also called acute or toxemic schistosomiasis and occurs, in genera, after three to nine weeks
of cercariae penetration, when they have already become adult worms and start laying eggs.
Toxemia is secondary to hypersensitivity reactions to the parasite, being characteristic to pa‐
tients who do not reside in endemic areas and that are exposed to contaminated water bod‐
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ies [15,16]. This form presents with fever, chills, cough, weakness, weight loss, diarrhea,
vomiting, urticarial reactions, hepatosplenomegaly and eosinophilia. These manifestations
last, in general, a few days but can last months and, in rare cases, be fatal. These patients
present big periovular necrotic-exudative granulomas dispersed throughout the intestines,
liver and other organs [17], and generally present spontaneous clinical improvement after a
few weeks, but treatment associating schistosomicides and corticosteroids reduce the persis‐
tence time of symptoms and prevents evolution into the chronic phase.
Species Regions where it occurs Main affected organs Most common neurological
forms
S. mansoni Sub-Saharan Africa, Brazil,
Egypt, Middle-East, other
regions in Africa and in the
Americas
Liver, spleen and intestines Spinal cord schistosomiasis
(mainly) and cerebral
schistosomiasis
S. haematobium Sub-Saharan Africa, Brazil,
Egypt, Middle-East, other
regions in Africa
Bladder, urethra and ureter Spinal cord (mainly) and
cerebral schistosomiasis
S. japonicum and S.
japonicum-like
China, South-East Asia and
Pacific islands
Liver, spleen and intestines Cerebral schistosomiasis
(mainly) and spinal cord
schistosomiasis
Table 1. Geographic distribution, usually affected organs, and most frequent neurological forms according
Schistosoma species
2.2. Chronic phase
Schistosomiasis'  chronic  phase  is  frequently  asymptomatic.  Symptoms  occur  with  more
frequency in  patients  who are  repeatedly exposed to  transmissions focuses  and end up
developing high worm burden.  Chronic forms depend on the involved species.  Schisto‐
somiasis mansoni chronic forms are usually classified as: intestinal, hepatointestinal, hep‐
atosplenic  and  decompensated  hepatosplenic.  In  the  intestinal  and  hepatosplenic  forms
patients  usually  do  not  present  significant  symptoms,  but  when  present  they  may  in‐
clude abdominal discomfort, fecal urgency, episodes of diarrhea with eventual mucus or
blood. Hepatic lesions are caused by egg embolism secondary to inflammatory reaction,
but  without  significant  clinical  repercussions.  With progression of  infection and chronic
inflammatory  process,  these  patients  may present  significant  periportal  fibrosis,  leading
to portal hypertension. This phase is called hepatosplenic and the patient may suffer as‐
cites  and  severe  esophageal  varices  [17].  Schistosomiasis  japonica  may  cause  the  same
kinds of manifestations, although liver function is usually more compromised. In schisto‐
somiasis  haematobia,  oviposition  may  cause  bladder  inflammation,  alongside  blood  in
the urine and urinary urgency.  Lesions in the urinary tract  may cause fibrosis  and uri‐
nary obstruction, leading to obstructive uropathy and increasing the risk of bladder can‐
cer.  These  chronic  forms  depend fundamentally  on  high  worm burdens,  therefore  they
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are diseases that  affect  mainly inhabitants  of  endemic areas.  For instance,  hepatosplenic
forms of  schistosomiasis  mansoni  are  more frequent  in  areas  with high endemicity  and
very rare in areas of  low endemicity.  Differently,  ectopic forms of schistosomiasis occur
as consequence of egg or work accumulation in any organ of the patient and, therefore,
is not related to high worm burdens. Thus, it  can occur in patients of endemic areas or
in patients of non-endemic areas with casual exposure to the focus of transmission.
3. Spinal cord schistosomiasis
The human central nervous system (CNS) may be affected by infections of several species in
the Schistosoma genus that infect men, excluding S. intercalatum. Curiously, other species of
Schistosomatidae, such as Trichobilharzia regenti, may cause brain or medullar lesions in wa‐
ter birds, but in man causes only swimmer's itch [18-20]. The first human case of neurologi‐
cal lesion cause by Schistosoma was described in 1889 by Yamagiwa in the necropsy of a
patient with epilepsy that presented cerebral granulomas. It is curious that S. japonicum life
cycle was described 15 years later, a fact that allowed the a posteriori identification of the
eggs present in those granulomas [21,22]. In 1905, Shimamura and Tsunoda demonstrated
for the first time the presence of S. japonicum in the spinal cord of a patient with transverse
myelitis. Despite the fact that S. japonicum was the first species described as a cause of spinal
cord medullar lesion, this species has been the less frequently associated with such lesions in
the Schistosoma genera. The first case of medullar lesion caused by S. mansoni was described
in 1930 by Muller and Stender and found in a 26 year old patient who had been to Brazil. In
1948, Faust published a review on the 82 cases of ectopic schistosomiasis described thus far
[23]. Among these, there were 56 patients with brain compromising and 8 with medullar le‐
sions in the spinal cord. In that occasion, the author highlighted the importance of this form
of disease, given that the number of cases was not inconsiderable and that the consequences
were, in general, devastating. “In reports of the cases, it has been customary that most au‐
thors address ectopic schistosomiasis as rare or really rare. These designations are no more
applicable, despite these syndromes being relatively infrequent” [23]. In the same year, Kane
and Most wrote yet another review article on literature concerning neurological lesions
caused by Schistosoma, including the medullary and brain forms, and called attention to the
occurrence of 25 cases of cerebral neuroschistosomiasis japonica among north-American sol‐
diers in the Second World War, between the years of 1944 and 1946 [24]. In this study, 88%
(22 cases) of the initial fecal exams of North-American military patients with cerebral neuro‐
schistosomiasis japonica were negative for eggs in the stool samples in the first examination
and that 40% (10 cases) remained negative after several serial examinations. All patients had
confirmation of Schistosoma eggs in pathological anatomy examinations, obtained through
CNS biopsy or necropsy. The author, at the time, already said that “Cautious and repeated
fecal examinations are important for clinical diagnosis, but specific treatment must not be
postponed if there are adequate evidence for presumptive diagnosis, even because all fecal
examinations may be negative for eggs even when the patient already shows neurological
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symptoms”. Despite the fact that the authors were referring to cerebral neuroschistosomiasis
japonica, the same advice is valid for spinal cord schistosomiasis today.
Up until the 1980's, medullar lesion caused by Schistosoma was, in most published cases,
confirmed through fragments of nervous tissue obtained through biopsy or necropsy. In
1985, Scrimgeour and Gedjusek published a scientific literature review of the years between
1930 and 1984 in which they identified 52 cases of spinal cord schistosomiasis mansoni and
12 cases of spinal cord schistosomiasis haematobia, confirmed by pathological anatomy me‐
dullar examinations. On the occasion, the authors highlighted the importance of suspecting
neuroschistosomiasis in any patient who had been exposed to the risk of infection and pre‐
sented neurological manifestations [25]. The authors reaffirmed that the patients in general
had no previous manifestation of schistosomiasis and that only 22% of S. mansoni carriers
had eggs found in their feces or rectum biopsy and only 25% of the S. haematobium carriers
had eggs found in their urine or feces [25]. This difficulty in finding the eggs is not casual,
nor an abnormal occurrence. It is part of the disease's laboratory findings pattern [26]. De‐
spite having already done some serological examinations that could have confirmed infec‐
tion by the parasites even without finding eggs, the diagnosis of spinal cord schistosomiasis
was still very complicated and controversial at that time, specially because there were no de‐
tailed imaging examinations. Some studies already used presumptive diagnosis criteria, in
which the presence of lower thoracic or high lumbar medullar symptoms, the demonstra‐
tion of exposure to Schistosoma through parasitological or immunological methods, and the
exclusion of other causes for myelitis were enough for attributing the clinical manifestation
to spinal cord schistosomiasis [27]. There were, still, some divergences in the literature re‐
garding the acceptance of the parasitological e/or immunological methods for case confirma‐
tion, but the risk of sequelae involved in biopsying the medulla led to the confirmation of
the diagnosis through pathological anatomical methods being abandoned [28-31]. In the last
decades, spinal cord schistosomiasis diagnosis has been reached through confirmation of
Schistosoma infection using pararitological or serological methods associated with the exclu‐
sion of other causes for myelopathy [32-37].
With  the  technological  improvement  in  the  field  of  immunological  methods  and  imag‐
ing  examinations,  including  the  introduction  of  Computerized  Tomography  (CT)  and,
mainly,  Magnetic  Resonance  Imaging  (MRI),  differential  diagnosis  with  other  causes  of
myelopathy has become easier. This can explain, at least in part, the great amount of ar‐
ticles being published in this area [22,38-44].  With the increase in interest  for adventure
tourism, a growing number of spinal cord schistosomiasis cases, who live in non-endem‐
ic areas and are infected in their leisure time, have been described in the literature. Spi‐
nal  cord schistosomiasis,  which had been considered a  rare  disease  from the  beginning
of  the  20th  century to  the  early  80's,  now appeared to  have been,  in  fact,  under-recog‐
nized. In the last years, it has attracted more and more the interest of researchers and is
considered one of  the forms of  schistosomiasis that  must be reevaluated from the point
of view of disease burden by Public Health Organizations [45].
There are, in the literature, studies that allow an evaluation on the incidence or prevalence
in the population with schistosomiasis or exposed to the risk of schistosomiasis. In biblio‐
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graphical studies of international literature between 1930 and 1984, 64 patients were identi‐
fied (12 with S. haematobium and 52 with S. mansoni) and described in the literature [25].
Another bibliographical study published, which included 12 years worth of publications,
identified 280 patients with described in the literature [21]. This sudden increase in the num‐
ber of publications regarding this disease reiterates the hypotheses that the improvement in
diagnostic methods has allowed an increase in the recognition of this disease. Thus, neuro‐
schistosomiasis must now be recognized as a problem to be considered by the developers of
public policies.
The proportion of patients who go from schistosomiasis to spinal cord schistosomiasis is un‐
known. But a study done in Bahia with 212 patients with non-traumatic medullar lesion
shows that 9.9% (21 cases) of patients had schistosomotic etiology [30]. In another, similar
study performed at the Sarah Kubitschek Hospital, in Brazil, with 231 patients, this etiology
corresponded to close to 6% of the patients (13 cases) of non-traumatic medullar lesion seen
in 4.5 years [36]. There are several indications that this disease has been under-diagnosed
[46-49] in endemic areas because of the difficulty of access to more sophisticated diagnostic
methods and, in more developed areas, because of the lack of knowledge on the part of the
doctors about this disease [26]. This situation has been changing in the last years, particular‐
ly in Brazil, due to the improvement in diagnostic tools and better access to medical atten‐
tion in the country. This may explain the increase of cases in patients of this country that are
reported in the literature.
Knowledge of the epidemiological profile of the patient with spinal cord schistosomiasis can
be obtained based on case reports or serial cases [26, 42, 50-52]. Spinal cord schistosomiasis
occurs more frequently in male patients, with ages between 15 and 50, having low worm
burden, up until then not presenting symptomatic neuroschistosomiasis, presenting intesti‐
nal and hepatointestinal forms, living in non-endemic areas (who had an eventual exposure
to risk of infection) or in endemic areas.
There are several indications that a greater risk for spinal cord schistosomiasis cases in pa‐
tients is present for patients with low worm burdens [53-55]. This means that spinal cord
schistosomiasis can occur in patients with low risk for severe hepatosplenic forms. They are
patients who do not present symptoms relating to the digestive tract, which often may lead
the assisting physician not to think of schistosomiasis diagnosis. Other patients, aside from
not having digestive symptoms, are not frequently exposed to the risk of transmission, mak‐
ing the diagnosis even harder. Examples of said patient profile are tourists who have been
only sporadically exposed in areas of schistosomiasis transmission [27, 56, 57], patients who
live in urban areas who, usually, have sporadic contact with transmission focuses [58], resi‐
dents of areas that are recent focuses of transmission [56], and residents of areas with low
prevalence for schistosomiasis [26].
Despite the severity of sequelae and disabilities caused by spinal cord schistosomiasis, this
form of schistosomiasis is still not being considered in the development of public policies
that aim to control the morbidity of schistosomiasis [1, 45, 58].
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4. Physiopathology
Knowledge on spinal cord schistosomiasis physiopathology has greatly improved in the last
years, although some blanks still remain. It is known that periovular granulomas play a cen‐
tral role in medullar lesion [54, 55]. Although signs of vasculitis with immune complexes de‐
posits close to the granulomas can be found [59], it is believed that these findings have a
secondary role in the lesion. The mass effect produced by the granuloma and the edema that
surrounds it may lead to the compression of internal structures to the spinal canal, causing
secondary and definitive ischemic lesions. The eggs get to the medulla via the Batson venus
plexus through embolization or through anomalous worm migration, in which case they
would lay their eggs next to the medulla [54, 55]. This plexus was first described in 1940 by
Batson, who intended to explain a mechanism for metastases being dispersed to the CNS
[60]. It is a network of valveless veins that connects the inferior vena cava to the veins in the
vertebrae. This plexus allows the embolization of eggs without the need for collateral circu‐
lation or arteriovenous shunts, seen only in the hepatosplenic and cardiopulmonary forms
of schistosomiasis. The eggs of S. mansoni and of S. haematobium are larger, oval-shaped and
have spine (terminal in S. haematobium and lateral in S. mansoni), which may explain why
these species are associated with different neurological manifestations, most of them attrib‐
uted to lesions in the lower levels segments of spinal cord, and, less frequently, higher mani‐
festations in the spinal cord's medulla [54]. S. japonicum eggs are smaller, lack a spine, and
are round, allowing them to reach the brain more easily through these anastomoses, causing
a smaller proportion of medullar lesions. The probability of these eggs getting to the places
where the lesion occurred through ectopic oviposition is reinforced in some situations, in
which several eggs are found very close together, or even creating cordons. Aside from that,
worm couples were found near these locations in medullar veins. The highest proportion of
causes occurring in man can be explained by their greater exposure to focuses of transmis‐
sion and by differences in pelvic anatomy between both sexes [54].
The greater  proportion of  spinal  cord schistosomiasis  cases  in  patients  who present  the
initial  form  of  schistosomiasis  when  compared  to  the  ones  who  present  the  advanced
form appears to have immunological and hemodynamic reasons. Pittella and Lana-Peixo‐
to  studied  extensively  the  occurrence  of  Schistosoma  eggs  in  necropsy  nervous  tissue
samples, and found eggs in 26% of the patients who presented hepatosplenic forms and
61,1%  of  the  patients  who  presented  cardiopulmonary  forms  [53,  61].  Periovular  reac‐
tions  in  the  CNS are  intense  in  patients  presenting  medullary  forms of  neuroschistoso‐
miasis,  with  periovular  necrotic-exudative  granulomas  that  are  typically  found  in  the
initial stages of the disease (Figures 1 and 2).
Patients with hepatosplenic and cardiopulmonary forms usually present discreet periovular
reaction, without granulomatous response or with smaller granulomas, in non-productive
stages and located in several regions of the CNS [53-55, 61, 62]. Only 10% of the patients
who had eggs in the CNS in the necropsy, and presented these advanced forms also present‐
ed neurological symptoms when alive. [53]. One of the suggested mechanisms to explain
egg dispersion in cases of patients with hepatosplenic and cardiopulmonary schistosomiasis
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is that the eggs would get to the CNS by bypassing through collateral portal-like circulation
and intrapulmonary arteriovenous shunting, secondary to hemodynamic alterations com‐
mon to these advanced forms of schistosomiasis. In these cases there is major egg dispersion
through the CNS through anastomoses, but few of these eggs cause symptoms given that
the inflammatory response in these patients is usually discreet. In patients presenting schis‐
tosomiasis in the intestinal and hepatointestinal forms, the most viable way for the worm
couples to reach the CNS is Batson's plexus and, therefore, the most common neurological
forms are medullary.
Figure 1. Periovular reaction with granuloma in spinal cord biopsy fragment of a patient with neuroschistosomiasis
caused by Schistosoma mansoni infection (Optical microscopy, hematoxiline eosine method).
Figure 2. Periovular reaction with granulomatous response in spinal cord biopsy fragment of a patient with neuro‐
schistosomiasis caused by Schistosoma mansoni infection (Optical microscopy, hematoxiline eosine method).
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5. Schistosomiasis and immune response
During the disease's evolution, immune responses change over time, there being several cy‐
tokines that participate with different responses at each moment. Immediately after infec‐
tion by Schistosoma, there is a predominance of T-helper (Th) lymphocytes in action,
producing interferon gamma (INF-γ), interleukin (IL)-2, and tumor necrosis factor (TNF)-α.
This stage usually lasts an average of 5 to 6 weeks in murine models that corresponds to the
acute phase of the disease (Katayama Fever) in humans [63-65]. With the evolution of the
disease, this response is substituted by Th2 type and its associated cytokines are IL-4, IL-5,
IL-10 and IL-13. At this stage, it is more common for spinal cord schistosomiasis to happen,
as shown by the elevated concentration of these cytokines not only in the CSF, but also in
the blood and serum from patients with spinal cord schistosomiasis [66]. Concentration of
TH1 type cytokines found in patients with spinal cord schistosomiasis was also lower than
in patients from the control group. In other words, spinal cord schistosomiasis seems to be
more common in patients who present TH2 type of immunological responses, correspond‐
ing to the initial chronic phase of the patient with schistosomiasis, right after the acute phase
of the disease, but that may last for years. CD4+ T-cells (T-helper) play a central role in the
formation of the granuloma, so much so that in rats without a thymus there is no formation
of granulomas and patients with CD4+ T-cell depletion granulomas that may form are, gen‐
erally, smaller [63-65].
With the evolution of schistosomiasis, TH2 polarized response is attenuated by suppressor
T-cells, which modulate immune response, diminishing the production of cytokines, inhibit‐
ing the formation of granulomas, and diminishing the size of the granulomas that do form
[63-65], a situation which has been observed in patients with hepatosplenic and cardiopul‐
monary schistosomiasis. This may explain the reason why there are many patients with ad‐
vanced forms who present multiple eggs in the CNS, without inflammatory reaction around
them and that, therefore, do not elicit any symptom [54, 55, 66].
6. Clinical manifestations
The typical  clinical  manifestations of  spinal  cord spinal  cord schistosomiasis  is  acute  or
subacute  and  presents  with  lumbar  pain  with  or  without  radiation  to  lower  limbs,
evolving  with  diminishing  of  muscular  strength  in  these  limbs,  with  the  possibility  of
presenting, in addition, sensory alterations such as hypoaesthesia, paresthesia and dyses‐
thesia  [26].  Clinically,  there  may  be  myeloradicular  or  radicular  compromising  of  the
medulla,  with  lesions  in  several  segments  of  the  medulla.  Lesions  which  are  higher  in
the spinal cord and in a functional section of the medulla may present signs of pyrami‐
dal liberation, such as Babinski's or hyperreflexia in the lower limbs. Lower lesions may
present  themselves  as  cauda  equina  syndrome  with  hypo-  or  areflexia  in  the  lower
limbs and unresponsive plantar-cutaneous reflex. Patients with spinal cord schistosomia‐
sis usually present fecal and urinary retention, or other sphincter alterations, aside from
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erectile  dysfunction  [26].  The  amount  of  time  between  the  beginning  of  the  symptoms
and the establishment of the complete manifestation normally ranges from a few days to
a  couple  of  weeks  [21,  26,  66-68].  In  general,  these  patients  do  no  present  systemic
symptoms.  Some patients  may present  cephalalgia,  vomiting and other  signs  of  menin‐
geal irritation, such as Kernig's,  Brudzinski's or nuchal rigidity [67].  When there is radi‐
culopathy,  patient  may present  Lasègue's  sign.  Spinal  cord schistosomiasis'  typical  triad
is diminishing of muscular strength, with sensory alterations in the lower limbs associat‐
ed with bladder dysfunction, this triad is found in 92,6% of the cases [26].
7. Diagnosis
Spinal cord schistosomiasis' diagnosis it not always simple, but there is a consensus that an
adequate diagnosis must include typical clinical manifestation (medullar and/or radicular
symptoms), proof of exposure to Schistosoma through parasitological or immunological
methods, and exclusion of other possible causes of myelopathy [26, 27, 32-37, 67-69].
 
(a) (b) (c) 
Figure 3. a-c). Sagital magnetic ressonance imaging in T1 phase (Figure 3a), no contrast T2 phase (Figure 3b), and
contrast T2 phase (Figure 3c) in a spinal cord schistosomiasis patient.
8. Imaging examinations
MRIs are very important when investigating spinal cord schistosomiasis and may show im‐
portant data about the location and extension of the lesions. Although it's not a examination
that can define completely the etiology, it may collaborate to differential diagnosis by show‐
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ing inflammatory lesions and ruling out tumorous lesions. The affected area may present
with increased volume or just an increase of paramagnetic contrast caption (Figures 3a, 3b,
and 3c). The most frequently found aspect is a granulated pattern that may not be exclusive
to, but is highly suggestive of, spinal cord schistosomiasis (Figures 4 and 5). A CT picture
has a lower sensibility and, in some cases, may show evidence of increased volume or just
high contrast caption [30, 38, 39, 41, 43, 44, 50, 68-71].
Figure 4. Sagital magnetic ressonance imaging (T2 phase) in a spinal cord schistosomiasis patient. It is observed a
granular impregnation of gadolinium magnetic contrast in thoracic-lumbar spinal cord.
9. Laboratory examinations
Nonspecific examinations may suggest the etiology in a clinically suggestive patient. Rou‐
tine CSF examination may show alterations in a high percentage of the cases, such as in‐
crease in proteins in 95% and of leukocytes in 98% of the cases, generally with
predominance of lymphocytes and presence of eosinophil granulocytes in 40.8% of the cases
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[28]. Despite being highly suggestive of spinal cord schistosomiasis, pelocytoses, high pro‐
tein concentration and eosinophilia in CSF are not always present [28].
Figure 5. T2 phase axial magnetic ressonance imaging in a spinal cord schistosomiasis patient. It is observed a hyper‐
signal in the thoracic-lumbar spinal cord levels.
Identifying the Schistosoma infection through the presence of eggs in the feces (S. mansoni
and S. japonicum) or urine (S. haematobium) presents less sensitivity than immunological ex‐
aminations. In the case of S. mansoni, sensitivity varies depending on the methodology and
the number of samples being 15.4% [36], 40.0% [26], or 42.5% [42]. Among the several techni‐
ques for parasitological examinations, the one which presents the highest sensitivity for S.
mansoni is Kato-Katz. A study in which 3 to 5 serial fecal samples were collected detected
eggs in the feces of 59.4% of the patients [51]. Rectal biopsy, when identifying eggs, shows a
positivity ranging from 57.5% [42] to 88,9% [51]. Given that parasitological examinations
may be considered to have 100% specificity, any of these tests returning a positive must be
considered proof of Schistosoma infection, but it may not exclude schistosomiasis when re‐
sults come back negative.
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There are several immunological examination techniques to be used in the serum or CSF.
The most used ones try to reveal the presence of antibodies which are specific for soluble
egg antigens (SEAs), antigens from the digestive tube of adult worms, or antigens from cer‐
cariae. The most used serology techniques are ELISA (Enzyme-linked immunosorbent as‐
say) or indirect immunofluorescence assay. Immunological blood examinations have a
sensitivity varying between 80% and 97% and when tested on CSF sensitivity may vary be‐
tween 56% to 97% (22, 26, 35, 68, 69, 72]. Immunological examinations must be considered as
strong evidence of active Schistosoma infection, even though many patients who have been
cured of the parasites still test positive for a long time and also that there is a chance of
cross-reaction with other parasites. Biopsying the medulla is only done, nowadays, in cases
when after extensive investigation, the need to rule out tumors is still present [26, 51, 68, 69,
72, 73]. It becomes apparent that no examination may be considered as gold standard for the
diagnosis of Schistosoma infection and, therefore, analysis of specific examinations must oc‐
cur alongside analysis of clinical and epidemiological aspects. Also, results from imaging ex‐
aminations and presence of eosinophil granulocytes in CSF or eosinophilia in peripheral
blood must be considered.
A  proper  investigation  must  be  done  to  exclude  other  causes  for  the  medullar  and/or
radicular  lesion,  such  as  bacterial  infections  (e.g.  tuberculosis,  syphilis,  abscesses),  viral
infections  (e.g.  cytomegalovirus,  poliovirus,  enterovirus,  HZV,  HSV-1,  HSV-2,  HIV,
HTLV-I) parasitic diseases (e.g.  cysticercosis,  toxoplasmosis),  fungal infections or non-in‐
fectious,  such  as  neoplasia,  systemic  lupus  erythematosus,  auto-immune  vasculitis,  dia‐
betic  vasculitis,  B12  vitamin  deficiency,  multiple  sclerosis,  Guillan-Barré  Syndrome,
among others [26, 51, 68, 69, 72, 73].
10. Treatment
Treatment is done through the use of corticosteroids and schistosomicides. The corticoste‐
roids will diminish the inflammation and lead to regression of the granuloma, being even
more important than the schistosomicide. The latter will eliminate the egg production by
killing the adult worms and indirectly diminish the production of soluble egg antigens,
which are important stimuli for the granulomas. In a few cases, surgical procedures may be
necessary to decompress medullar structures. In other cases, treatment is clinical [26, 51, 73].
The schistosomicide may be oxamniquine (15 mg/kg dose for adults and 20 mg/kg for chil‐
dren with up to 5 years of age) or praziquantel (60 mg/kg for children with up to 15 years of
age and 50 mg/kg for adults), both in a single dose [73]. The corticosteroid dose is the equiv‐
alent to prednisone 1 mg/kg/day, and must be administered for 6 months, with careful sus‐
pension, given that patients may present relapses during the process.
In addition, complementary care involves adequate integral approach with psychosocial re‐
habilitation and motor physical therapy, intermittent bladder checking, prevention of pres‐
sure ulcers, among others. Special care must be taken regarding urodynamic aspects [26, 70,
73]. The use of laxatives or enema may be needed for patients with fecal retention.
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11. Prognosis
Evolution depends, fundamentally, on early diagnosis and care, better prognosis being asso‐
ciated with an early introduction of the treatment, and particularly the introduction of glu‐
cocorticoids [26]. Although symptoms and urological functional alterations do not always
respond well to adequate treatment, despite its being started precociously [26, 70, 74, 75].
Patients may recover motor function, sensitivity, sphincter and erectile function control, or
they may end up with any combination of absence or recovery of some of the aforemen‐
tioned functions. Urodynamic alterations have not shown significant improvement in pa‐
tients who underwent protocol treatment. Ferrari and colleagues (2004) found complete
recovery in 31.7% (20) of the patients, 28.3% (18) of the patients presented partial recovery
with no functional limitation, 25.4% (16) patients presented partial recovery with functional
limitation, and 14.3% (9) of the patients did not improve at all [51]. There were no deaths in
this case series. Among the sequelae are paraplegia, paraparesis, dysfunction in the bladder
or anal sphincter, sexual dysfunction, definitive sensitivity loss in the affected areas or even
paraesthesia and dysesthesia [26, 30, 51]. Detailed studies on the urological aspects, done by
Lima (2004) in the Hospital da Restauração in Recife, PE, show that after 9 months of treat‐
ment 52 (80%) of 65 patients, showed alterations in urodynamic examinations and 45
(69.2%) showed alterations in voiding cystourethrogram [74].
12. Perspectives
Several factors can actively contribute to the increase in the identification of spinal cord
schistosomiasis cases, such as: improvement in diagnostic resources, increase in ecotourism
activities with greater exposure of the population to risk of infection, growth of the trans‐
mission area, even in urban areas, and lowering of high parasitical loads, without diminish‐
ing of the global prevalence of schistosomiasis. There is need of investing in the study of
spinal cord schistosomiasis, focusing epidemiological aspects such as: prevalence and inci‐
dence, relations between general schistosomiasis incidence and spinal cord schistosomiasis,
prevalence and incidence in areas of high and low endemicity, and predisposing factors. De‐
spite how successful controlling the hepatosplenic and cardiopulmonary forms has been
throughout the years, control instruments used currently have not shown themselves as suf‐
ficient to control the spinal cord schistosomiasis problem. More studies are needed for im‐
proving the understanding on the real prevalence of the medullary forms of schistosomiasis.
Changes in the Health Surveillance Systems are needed to improve control of schistosomia‐
sis, aiming at a better understanding of the schistosomotic morbidity, particularly that of
spinal cord schistosomiasis. It is not surprising that schistosomiasis control politics, based
on parasitical diagnostic and treatment of the infected, have not been able to reduce the
morbidity of the disease due to medullar lesions, since most patients who present this form
of schistosomiasis have low worm burdens and present with negative fecal examinations.
To reach effective control of spinal cord schistosomiasis, the introduction of more sensitive
diagnostic methods and the development of more effective medicines for diagnosis and
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treatment of mild forms of schistosomiasis with low worm burdens will be needed in the
basic health systems. For an initial diagnosis, the possibility of immediate introduction of se‐
rology as a diagnostic instrument in the Basic Health Units. This examination can be used as
diagnostic in those patients who are still untreated. But more studies will be necessary for
the development of more effective medicines and of more sensitive methods for parasitolog‐
ical removal. It is also important to disclose the occurrence of this form of schistosomiasis, as
well as capacitating professionals for attending these patients, particularly in endemic areas
and recently formed focus points. A secondary gain of disclosing information on the exis‐
tence of severe forms may be the population increase in attendance to control measures for
this disease.
Differential diagnosis:
• Bacterial infections: tuberculosis, syphilis, abscesses, Lyme's disease.
• Viral infections: cytomegalovirus, poliovirus, enterovirus, HZV, HSV-1, HSV-2, HIV, HTLV, EBV, HBV.
• Other infections: cysticercosis, toxoplasmosis, Chagas disease, fungal infections
• Non-infectious: neoplasia, systemic lupus erythematosus, auto-immune vasculitis, diabetic vasculitis, B12 deficiency,
multiple sclerosis, polyradiculopathy, Guillan-Barré Syndrome, spinal disc herniation, syringomyelia
Typical clinical manifestation:
• Lumbar pain with or without radiation to lower limbs
• Paraesthesia or diminishing of lower limb sensitivity
• Paraparesis or paraplegia
• Anal and bladder sphincter dysfunction
• Evolution is generally acute or subacute (between 2 to 60 days)
Presumptive diagnosis:
• Low thoracic or high lumbar medullar symptoms,
• Proof of exposure to Schistosoma ssp through parasitological or immunological methods and
• Exclusion of other causes for myelitis
Typical epidemiological profile of patients with spinal cord schistosomiasis:
• Ages between 15 and 50
• Predominantly male
• Low worm burden
• Patients thus far do not present symptomatic schistosomiasis or present intestinal and hepatointestinal forms (IS or
HIS)
• Patients may reside in endemic areas or non-endemic areas, with eventual exposure to risk of infection
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